Celltrion’s Avtozma® (CT-P47) Biosimilar Receives European Commission Approval Celltrion has announced that the European Commission (EC) has granted marketing authorization for Avtozma® (CT-P47), a biosimilar to RoActemra® (tocilizumab). Avtozma® is approved for all indications of its reference product, RoActemra®, including…
QIAGEN Files Lawsuit Against bioMérieux to Protect QuantiFERON Technology QIAGEN has taken legal action to protect its intellectual property (IP) by filing a lawsuit against bioMérieux S.A. for patent infringement. The lawsuit, lodged in the Local Division of the Court…
Ansell Expands Portfolio with Kimtech, KleenGuard, and RightCycle in North America and Europe Ansell Limited, a global leader in protection solutions, has announced that it will begin accepting orders for Kimtech™ and KleenGuard™ products and managing customer inquiries across North…
Toray Opens New R&D Facility in Taiwan to Strengthen Semiconductor Technologies Toray Industries, Inc. has announced the opening of the Toray Taiwan Technical Center, a state-of-the-art facility designed to enhance research and development (R&D) in advanced semiconductor technologies and materials.…
Positive Phase III WAYPOINT Trial Results for TEZSPIRE® in Chronic Rhinosinusitis with Nasal Polyps Significant Reduction in Nasal Polyp Severity and Surgery Needs TEZSPIRE Phase III Trial Shows Benefits in Chronic Rhinosinusitis with Nasal Polyps Full results from the Phase…
BostonGene to Present AI Platform at Japanese Oncology Meeting BostonGene, a pioneering provider of AI-driven molecular and immune profiling solutions, is set to participate in the 22nd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2025), which will be…
WindBorne Systems Steps Up to Fill Atmospheric Data Gap After NWS Weather Balloon Suspension Introduction: NWS Suspension of Weather Balloon Launches in AlaskaThe National Weather Service (NWS) recently announced it would indefinitely suspend its weather balloon launches in Kotzebue, Alaska,…
Ketogenic Diet Benefits Mental and Physical Health in Bipolar Disorder Baszucki Group Launches Pilot Study on Ketogenic Diet for Bipolar Disorder The Baszucki Group has launched a groundbreaking pilot study investigating the effects of the ketogenic diet on individuals with…
Palforzia® Oral Immunotherapy for Peanut Allergy Now Available for U.S. Children Aged 1-3 Stallergenes Greer Launches Palforzia® for Peanut Allergy in U.S. Toddlers Aged 1-3 Stallergenes Greer, a global leader in allergy therapeutics, has announced the launch of Palforzia® [Peanut…
Kiyatec Inc. Receives Prestigious CAP Accreditation and New York State Approval for 3D Predict™ Kiyatec Inc., a leader in patient-specific cancer diagnostics, has announced its laboratory’s successful accreditation by the College of American Pathologists (CAP) and the receipt of New…
Astoria Therapeutics Launches ALPHA-ORBIT Phase 3 Trial for Navenivart in Hereditary Angioedema Astoria Therapeutics, a biopharmaceutical company focused on developing breakthrough therapies for allergy and immunology disorders, has announced the initiation of the ALPHA-ORBIT trial, a pivotal Phase 3 clinical…
Cynosure Lutronic and Amico Aesthetics Forge Strategic Distribution Partnership in the Middle East Partnership Overview Cynosure Lutronic, a global leader in energy-based devices, has entered into a multi-country distribution agreement with Amico Aesthetics, a top provider of world-class medical devices…